|
|
||||||||
Articles |
OBJECTIVE: To examine the predictive value of amniotic fluid (AF) insulin at 14-20 weeks' gestation for subsequent gestational diabetes and macrosomia in unselected gravidas 35 years or older at time of genetic amniocentesis. METHODS: We identified 296 pregnancies through stored AF samples from genetic amniocenteses (collected March 1987 through August 1992) in women meeting the following criteria: age 35 years or older, amniocentesis at 14-20 weeks, performance of a 50-g glucose challenge test, and adequate delivery data. RESULTS: A modified double-antibody radioimmunoassay reliably measured AF insulin with a detection limit of 0.35 microU/mL. Pregnant women in whom gestational diabetes was later diagnosed had higher median AF insulin levels than women who did not (0.60 versus 0.42 microU/mL, respectively; P = .026). A stepwise logistic regression analysis of gestational age at amniocentesis, maternal second-trimester weight, maternal age, and log AF insulin value on gestational diabetes showed only AF insulin to have a significant association with gestational diabetes (P = .004). Seven of 21 cases of gestational diabetes had AF insulin values exceeding the 95th percentile (1.33 microU/mL) compared with only 14 of 275 women with normal glucose tolerance (P < .001). Amniotic fluid insulin did not predict macrosomia in either nondiabetic or gestational diabetic pregnancies. CONCLUSION: Gestational diabetes is associated with increased AF insulin at 14-20 weeks, suggesting augmentation of fetal insulin production in the early fetal period in at least some cases of gestational diabetes.
This article has been cited by other articles:
![]() |
M. W. Carpenter, J. A. Canick, J. W. Hogan, C. Shellum, M. Somers, and J. A. Star Amniotic Fluid Insulin at 14-20 Weeks' Gestation: Association with later maternal glucose intolerance and birth macrosomia Diabetes Care, July 1, 2001; 24(7): 1259 - 1263. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. CARPENTER, J. A. CANICK, J. A. STAR, C. SHELLUM, and M. SOMERS A High-Sensitivity Assay for Amniotic Fluid Insulin at 14-20 Weeks' Gestation Obstet. Gynecol., November 1, 1999; 94(5): 778 - 782. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |